ArticleNature communications2025
Correlation stabilized anomalous Hall crystal in bilayer graphene.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fractional quantum anomalous Hall effect in moiré fractional Chern insulators.Nature materials · 2026Review
- Correlation stabilized anomalous Hall crystal in bilayer graphene.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
At low carrier densities, interacting electrons can form a Wigner crystal. Rhombohedral multilayer graphene hosts high-order Dirac fermions with nontrivial Berry phases. Using a beyond-mean-field theoretical framework, here we study the ground states of slightly charge-doped rhombohedral multilayer graphene under vertical displacement field. We find a Fermi liquid to trivial Wigner crystal transition at critical densities of ~1-2 × 10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.